Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by S100A13 is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. Additionally we are shipping S100A13 Kits (28) and S100A13 Proteins (22) and many more products for this protein.
Showing 10 out of 42 products:
Human Monoclonal S100A13 Primary Antibody for IF, WB - ABIN395794
Massi, Landriscina, Piscazzi, Cosci, Kirov, Paglierani, Di Serio, Mourmouras, Fumagalli, Biagioli, Prudovsky, Miracco, Santucci, Marchionni, Tarantini: S100A13 is a new angiogenic marker in human melanoma. in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010
Show all 5 references for ABIN395794
Human Polyclonal S100A13 Primary Antibody for ELISA - ABIN1997909
Viemann, Strey, Janning, Jurk, Klimmek, Vogl, Hirono, Ichida, Foell, Kehrel, Gerke, Sorg, Roth: Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. in Blood 2005
Show all 4 references for ABIN1997909
S100A13 interacts with the C2 domain of RAGE (show AGER Antibodies).
S100A13 is involved in cutaneous malignant melanoma resistance to DTIC/TMZ.
the IL1alpha (show IL1A Antibodies)-S100A13 tetrameric complex is the key complex formed during the non-classical pathway of IL1alpha (show IL1A Antibodies) release
S100A13 promotes the release of FGF-1 protein, but does not affect the transportation of FGF-1 protein in human umbilical vein endothelial cells.
S100A13 is expressed in melanocytic lesions when the angiogenic switch occurs and it may cooperate with VEGF-A (show VEGFA Antibodies) in supporting the formation of new blood vessels, favoring the shift from radial to vertical tumor growth.
Stress-induced export of IL-1alpha involves the intracellular association with the Cu2+-binding protein, S100A13; the expression of a S100A13 mutant functions as a dominant-negative repressor of IL-1alpha release.
S100A13 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells
data show that the expression of endoglin (show ENG Antibodies) and S100A13 protein corresponds to the activation of the endothelial cells in the process of endometriotic angiogenesis
In human astrocytic gliomas, S100A13 was significantly up-regulated in high-grade vascularized gliomas. Moreover, S100A13 expression significantly correlated with microvessel density and tumour grading.
Human S100A13 was heterologously expressed in Escherichia coli, purified and crystallized by the hanging-drop vapour-diffusion method.
The structure of S100A13 is characterized by a large patch of negatively charged residues flanked by dense cationic clusters contributed largely by the positively charged residues located at the C-terminal end.
The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. This protein is widely expressed in various types of tissues with a high expression level in thyroid gland. In smooth muscle cells, this protein co-expresses with other family members in the nucleus and in stress fibers, suggesting diverse functions in signal transduction. Multiple alternatively spliced transcript variants encoding the same protein have been found for this gene.
S100 calcium binding protein A13
, S100 calcium-binding protein A13
, protein S100-A13
, 8KDa amlexanox-binding protein